Order Article Reprints

Khojayeva K, Zhussipbekkyzy A, Balkybayeva D, Sabit K, Lopes LR, Sagatbekova K, Zhakupova A, Aljofan M. Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha–Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer. Biomedicines. 2026; 14(2):263. https://doi.org/10.3390/biomedicines14020263

Khojayeva, Kamilla, Aiym Zhussipbekkyzy, Dilbara Balkybayeva, Karakat Sabit, Lucia Rossetti Lopes, Kamila Sagatbekova, Assem Zhakupova, and Mohamad Aljofan. 2026. "Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha–Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer" Biomedicines 14, no. 2: 263. https://doi.org/10.3390/biomedicines14020263

Khojayeva, K., Zhussipbekkyzy, A., Balkybayeva, D., Sabit, K., Lopes, L. R., Sagatbekova, K., Zhakupova, A., & Aljofan, M. (2026). Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha–Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer. Biomedicines, 14(2), 263. https://doi.org/10.3390/biomedicines14020263